Home › NDC Lookup › RxCUI directory › RxCUI 2045244

{1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG... — RxCUI 2045244

RxNorm drug concept · Generic pack
RxCUI 2045244 Generic pack · GPCK ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2045244
Official name{1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack
Concept typeGeneric pack (GPCK)
RxNorm statusCurrent RxNorm concept
Also known as1 (ascorbic acid 7.54 GM / polyethylene glycol 3350 40 GM / potassium chloride 1.2 GM / sodium ascorbate 48.11 GM / sodium chloride 3.2 GM Powder for Oral Solution) / 1 (polyethylene glycol 3350 100 GM / potassium chloride 1 GM / sodium chloride 2 GM / sodium sulfate 9 GM Powder for Oral Solution) Pack
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)5,484 prescriptions · 21 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Polyethylene Glycol 3350: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You can generally expect a bowel movement within 1 to 3 days after taking it. It's not meant to work in an hour like some other laxatives — it works gradually. If you haven't gone...
  • How long does it take for Polyethylene Glycol 3350 to work?
  • You can stir it into any 4 to 8 ounces of beverage — water, juice, coffee, tea, whatever you like, cold or hot. The key is to stir it well until it's completely dissolved. Don't dr...
  • Can I mix it into any drink, or does it have to be water?
📖 Read our full Polyethylene Glycol 3350 guide →

🕸️ Concept Web — How {1 (ascorbic acid 7540 MG / polyethylene glycol... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept {1 (ascorbic acid 7540 MG / polyethylene glycol 3350 40000 MG / potassium chloride 1200 MG / sodium ascorbate 48110 MG / sodium chloride 3200 MG Powder for Oral Solution) / 1 (polyethylene glycol 3350 100000 MG / potassium chloride 1000 MG / sodium chloride 2000 MG / sodium sulfate 9000 MG Powder for Oral Solution) } Pack RxCUI 2045244

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 8

    The active substance itself — no strength, form, or brand attached yet.

    • Ascorbic acid 1151
    • Polyethylene glycol 3350 221147
    • Potassium chloride 8591
    • Sodium ascorbate 267366
    • Sodium chloride 9863
    • Sodium sulfate 36721
    • Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride 2045242
    • Polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate 2045232
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride Powder for Oral Solution 2045241
    • Polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Powder for Oral Solution 2045231
    • Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride Oral Powder Product 2045239
    • Ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride Oral Product 2045240
    • Polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Oral Powder Product 2045229
    • Polyethylene glycol 3350 / potassium chloride / sodium chloride / sodium sulfate Oral Product 2045230
    • Pack 746839
    • Oral Powder Product 1294711
    • +1 more in this family
  3. Clinical & branded drugs 11

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  4. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 25 of 29 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2045244 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65649-0400-01 1 KIT in 1 CARTON (65649-400-01) * 46.26 POWDER, FOR SOLUT... Plenvu Salix Pharmaceuticals, Inc 2018-05-04
65649-0400-02 1 KIT in 1 CARTON (65649-400-02) * 46.26 POWDER, FOR SOLUT... Plenvu Salix Pharmaceuticals, Inc 2018-05-04
Observed labelers: Salix Pharmaceuticals, Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.